KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Capital Leases (2016 - 2018)

Historic Capital Leases for Charles River Laboratories International (CRL) over the last 9 years, with Q4 2018 value amounting to $29.2 million.

  • Charles River Laboratories International's Capital Leases fell 349.83% to $29.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $29.2 million, marking a year-over-year decrease of 349.83%. This contributed to the annual value of $29.2 million for FY2018, which is 349.83% down from last year.
  • As of Q4 2018, Charles River Laboratories International's Capital Leases stood at $29.2 million, which was down 349.83% from $30.8 million recorded in Q3 2018.
  • Charles River Laboratories International's 5-year Capital Leases high stood at $37.4 million for Q2 2015, and its period low was $717000.0 during Q1 2014.
  • In the last 5 years, Charles River Laboratories International's Capital Leases had a median value of $30.3 million in 2017 and averaged $26.3 million.
  • Per our database at Business Quant, Charles River Laboratories International's Capital Leases surged by 342859.14% in 2015 and then plummeted by 1951.87% in 2016.
  • Charles River Laboratories International's Capital Leases (Quarter) stood at $1.0 million in 2014, then surged by 3260.0% to $33.6 million in 2015, then fell by 11.01% to $29.9 million in 2016, then increased by 1.34% to $30.3 million in 2017, then dropped by 3.5% to $29.2 million in 2018.
  • Its Capital Leases was $29.2 million in Q4 2018, compared to $30.8 million in Q3 2018 and $30.6 million in Q2 2018.